Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01126593 · ClinicalTrials.gov registry record · NA
Post-Op Rotator Cuff Pain Study With Subacromial Bupivacaine Infusion
A NA study, sponsored by Orlando Health.
- Completed
- Registry status
- NA
- Development phase
- 96
- Enrollment target
NCT01126593: Completed NA study, sponsored by Orlando Health.
NCT01126593 is a NA study that has completed, run by Orlando Health. The registered enrollment target is 96 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01126593, a NA study, has completed, sponsored by Orlando Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 96 participants
- Enrollment target
Study Summary
Subacromial pain catheters have been used with uncertain efficacy for many years after rotator cuff repair to aid in postoperative pain control. Our null hypothesis is that postoperative subacromial continuous infusion bupivacaine catheters will provide no pain control benefits over placebo infusions or no catheter use.
Primary Outcome
Pain was measured via Visual Analong Scale in measurement (0-100mm).
Interventions
- DRUG Normal Saline
- DRUG 0.5% bupivacaine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 96 participants |
| Start Date | 2008-12 |
| Est. Completion | 2010-02 |
| Phase | NA |
What the finished NCT01126593 record still lists
NCT01126593 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 96 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower).
The record links to 0 conditions, and to 2 interventions - of which Normal Saline is the first listed.
NCT01126593 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01126593 about?
NCT01126593 is a clinical study titled "Post-Op Rotator Cuff Pain Study With Subacromial Bupivacaine Infusion". Subacromial pain catheters have been used with uncertain efficacy for many years after rotator cuff repair to aid in postoperative pain control. Our null hypothesis is that postoperative subacromial continuous infusion bupivacaine catheters will provide no pain control benefits over placebo infusion...
What is the current status of trial NCT01126593?
This trial is currently completed. It is a NA study. The enrollment target is 96 participants. The study started on 2008-12. Estimated completion is 2010-02.
What interventions are being tested in trial NCT01126593?
The interventions under investigation include: Normal Saline (DRUG), 0.5% bupivacaine (DRUG).
Who is sponsoring clinical trial NCT01126593?
This trial is sponsored by Orlando Health, which has 21 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01126593's enrollment target sits among peer trials
96 925th of 2000 higher than 1,070 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03401762 · 96 participants · NA
Wearable MCI to Reduce Muscle Co-activation in Acute and Chronic Stroke
- NCT03471260 · 96 participants · Phase 1
Ivosidenib and Venetoclax With or Without Azacitidine in Treating Patients With IDH1 Mutated Hematologic Malignancies
- NCT03549559 · 96 participants · NA
Imaging Histone Deacetylase in the Heart
- NCT03841058 · 96 participants · Phase 2
Abaloparatide vs. Placebo in Post-Menopausal Women and Abaloparatide in Men Receiving Initial Spinal Fusion Surgery
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia